Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease

British Journal of Haematology

Volumn 154, Issue 1, 2011, Pages 150-153

  Qasim, Waseem ^a   Derniame, Sophie ^a   Gilmour, Kimberly ^a   Chiesa, Robert ^b   Weber, Martin ^b   Adams, Stuart ^b   Rao, Kanchan ^b   Amrolia, Persis ^a   Goulden, Nicholas ^b   Veys, Paul ^b   Gaspar, Hubert ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Graft versus host disease; Immunotherapy; Viruses

Indexed keywords

ALEMTUZUMAB; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GAMMA INTERFERON; HLA A2 ANTIGEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOVIRUS INFECTION; ADOPTIVE TRANSFER; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CHOLESTASIS; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; LETTER; LEUKEMIA RELAPSE; LIVER GRAFT REJECTION; LYMPHOCYTOPENIA; MESENCHYMAL STEM CELL TRANSPLANTATION; PERIPHERAL LYMPHOCYTE; PNEUMONIA; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE; VIRUS LOAD; WHOLE BODY RADIATION;

ADENOVIRIDAE INFECTIONS; ADOPTIVE TRANSFER; BYSTANDER EFFECT; CHILD; FEMALE; GRAFT VS HOST DISEASE; HUMANS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; T-LYMPHOCYTES;

EID: 79958847949     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08579.x     Document Type: Letter

References (10)

1. Chatziandreou, I., Gilmour, K.C., McNicol, A.M., Costabile, M., Sinclair, J., Cubitt, D., Campbell, J.D., Kinnon, C., Qasim, W. & Bobby, G.H. (2006) Capture and generation of adenovirus specific T cells for adoptive immunotherapy. British Journal of Haematology, 136, 117-126.
2. Di Genova, G., Roddick, J., McNicholl, F. & Stevenson, F.K. (2006) Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific. Blood, 107, 2806-2813.
3. Feuchtinger, T., Matthes-Martin, S., Richard, C., Lion, T., Fuhrer, M., Hamprecht, K., Handgretinger, R., Peters, C., Schuster, F.R., Beck, R., Schumm, M., Lotfi, R., Jahn, G. & Lang, P. (2006) Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. British Journal of Haematology, 134, 64-76.
4. Kampmann, B., Cubitt, D., Walls, T., Naik, P., Depala, M., Samarasinghe, S., Robson, D., Hassan, A., Rao, K., Gaspar, H., Davies, G., Jones, A., Cale, C., Gilmour, K., Real, M., Foo, M., Bennett-Rees, N., Hewitt, A., Amrolia, P. & Veys, P. (2005) Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. British Journal of Haematology, 130, 595-603.
5. Leen, A.M., Myers, G.D., Sili, U., Huls, M.H., Weiss, H., Leung, K.S., Carrum, G., Krance, R.A., Chang, C.C., Molldrem, J.J., Gee, A.P., Brenner, M.K., Heslop, H.E., Rooney, C.M. & Bollard, C.M. (2006) Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nature Medicine, 12, 1160-1166.
6. Leen, A.M., Christin, A., Myers, G.D., Liu, H., Cruz, C.R., Hanley, P.J., Kennedy-Nasser, A.A., Leung, K.S., Gee, A.P., Krance, R.A., Brenner, M.K., Heslop, H.E., Rooney, C.M. & Bollard, C.M. (2009) Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood, 114, 4283-4292.
7. Mackinnon, S., Thomson, K., Verfuerth, S., Peggs, K. & Lowdell, M. (2008) Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells. Blood Cells, Molecules, and Diseases, 40, 63-67.
8. Peggs, K.S., Verfuerth, S., Pizzey, A., Khan, N., Guiver, M., Moss, P.A. & Mackinnon, S. (2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet, 362, 1375-1377.
9. Rooney, C.M., Smith, C.A., Ng, C.Y., Loftin, S.K., Sixbey, J.W., Gan, Y., Srivastava, D.K., Bowman, L.C., Krance, R.A., Brenner, M.K. & Heslop, H.E. (1998) Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood, 92, 1549-1555.
10. Tough, D.F., Borrow, P. & Sprent, J. (1996) Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science, 272, 1947-1950.